The role of androgen receptor mutations in prostate cancer progression.

The nuclear receptor superfamily: the second decade

Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964 · see citing works

Gene regulation by steroid hormones

Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383 · see citing works

Molecular basis of agonism and antagonism in the oestrogen receptor

Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355 · see citing works

MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS

Tsai, M., & O’Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,887 · see citing works

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801 · see citing works

The development of androgen-independent prostate cancer.

Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326 · see citing works

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128 · see citing works

Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*

Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791 · see citing works

Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer

Taplin, M., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., & Balk, S. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322101 · Cited by 1,243 · see citing works

Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid

Renaud, J., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., & Moras, D. (1995) · Nature · doi:10.1038/378681a0 · Cited by 1,098 · see citing works

Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

Pike, A. C. W., Brzozowski, A. M., Hubbard, R. E., Bonn, T., Thorsell, A., Engström, O., Ljunggren, J., Gustafsson, J., & Carlquist, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4608 · Cited by 987 · see citing works

A canonical structure for the ligand-binding domain of nuclear receptors

Wurtz, J., Bourguet, W., Renaud, J., Vivat, V., Chambon, P., Moras, D., & Gronemeyer, H. (1996) · Nature Structural Biology · doi:10.1038/nsb0196-87 · Cited by 986 · see citing works

Determinants of target gene specificity for steroid/thyroid hormone receptors

Umesono, K., & Evans, R. M. (1989) · Cell · doi:10.1016/0092-8674(89)90051-2 · Cited by 948 · see citing works

Structure and specificity of nuclear receptor–coactivator interactionsPreprint

Darimont, B. D., Wagner, R. L., Apriletti, J. W., Stallcup, M. R., Kushner, P. J., Baxter, J. D., Fletterick, R. J., & Yamamoto, K. R. (1998) · Genes & Development · doi:10.1101/gad.12.21.3343 · Cited by 921 · see citing works

The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand

Rochel, N., Wurtz, J. M., Mitschler, A., Klaholz, B., & Moras, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80413-x · Cited by 842 · see citing works

Formation of the Androgen Receptor Transcription Complex

Shang, Y., Myers, M., & Brown, M. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00471-9 · Cited by 673 · see citing works

Atomic structure of progesterone complexed with its receptor

Williams, S. P., & Sigler, P. B. (1998) · Nature · doi:10.1038/30775 · Cited by 659 · see citing works

Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor

Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004571200 · Cited by 608 · see citing works

The nuclear receptor superfamily

Robinson‐Rechavi, M., Escrivá, H., & Laudet, V. (2003) · Journal of Cell Science · doi:10.1242/jcs.00247 · Cited by 588 · see citing works

Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element

Mader, S., Kumar, V., de Verneuil, H., & Chambon, P. (1989) · Nature · doi:10.1038/338271a0 · Cited by 500 · see citing works

Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone

Sack, J. S., Kish, K. F., Wang, C., Attar, R. M., Kiefer, S. E., An, Y., Wu, G. Y., Scheffler, J. E., Salvati, M. E., Krystek, S. R., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081565498 · Cited by 491 · see citing works

The Promoter of the Prostate-Specific Antigen Gene Contains a Functional Androgen Responsive Element

Riegman, P. H. J., Vlietstra, R. J., van der Korput, J. A. G. M., Brinkmann, A. O., & Trapman, J. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1921 · Cited by 448 · see citing works

Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies

Kazemi‐Esfarjani, P., Trifiro, M. A., & Pinsky, L. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.4.523 · Cited by 447 · see citing works

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

Veldscholte, J., Berrevoets, C., Ris‐Stalpers, C., Kuiper, G. G. J. M., Jenster, G. W., Trapman, J., Brinkmann, A. O., & Mulder, E. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90401-4 · Cited by 442 · see citing works

FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor

He, B., Kemppainen, J., & Wilson, E. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002807200 · Cited by 441 · see citing works

The structure of the nuclear hormone receptors

Kumar, R., & Thompson, E. B. (1999) · Steroids · doi:10.1016/s0039-128x(99)00014-8 · Cited by 433 · see citing works

Identification of two transcription activation units in the N-terminal domain of the human androgen receptor

Jenster, G., van der Korput, H. A. G. M., Trapman, J., & Brinkmann, A. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7341 · Cited by 419 · see citing works

Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen Promoter

Cleutjens, K. B. J. M., Eekelen, C. C. E.-V., van der Korput, H. A. G. M., Brinkmann, A. O., & Trapman, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6379 · Cited by 408 · see citing works

Structural basis of androgen receptor binding to selective androgen response elements

Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., & Gewirth, D. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401123101 · Cited by 400 · see citing works

Crystal structure of the human RXRα ligand‐binding domain bound to its natural ligand: 9‐cis retinoic acid

Egea, P. F., Mitschler, A., Rochel, N., Ruff, M., Chambon, P., & Moras, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2592 · Cited by 343 · see citing works

Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus

Ham, J., Thomson, A. A., Needham, M., Webb, P., & Parker, M. G. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.12.5263 · Cited by 339 · see citing works

A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences.

Zhou, Z. X., Sar, M., Simental, J. A., Lane, M. V., & Wilson, E. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36806-0 · Cited by 312 · see citing works

The androgen receptor gene mutations database (ARDB): 2004 update

Gottlieb, B., Beitel, L. K., Wu, J. H., & Trifiro, M. A. (2004) · Human Mutation · doi:10.1002/humu.20044 · Cited by 311 · see citing works

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.

Hsing, A. W., Gao, Y., Wu, G., Wang, X., Deng, J., Chen, Y., Sesterhenn, I. A., Mostofi, F. K., Bénichou, J., & Chang, C. (2000) · PubMed · Cited by 311 · see citing works

Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development

Cunha, G. R., Ricke, W. A., Thomson, A. A., Marker, P. C., Risbridger, G. P., Hayward, S. W., Wang, Y. Z., Donjacour, A. A., & Kurita, T. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.10.017 · Cited by 310 · see citing works

Androgen receptor mutations in prostate cancer.

Barrack, E. R. (1996) · PubMed · Cited by 301 · see citing works

Dynamics of Intracellular Movement and Nucleocytoplasmic Recycling of the Ligand-Activated Androgen Receptor in Living Cells

Tyagi, R. K., Lavrovsky, Y., Ahn, S., Song, C. S., Chatterjee, B., & Roy, A. K. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.8.0497 · Cited by 291 · see citing works

The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region

Cato, A. C., Henderson, D., & Ponta, H. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04763.x · Cited by 278 · see citing works

The androgen receptor gene mutations database

Gottlieb, B. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.151 · Cited by 271 · see citing works

Androgen receptor mutations in prostate cancer.

Marcelli, M., Ittmann, M., Mariani, S., Sutherland, R. W., Nigam, R., Murthy, L., Zhao, Y., DiConcini, D., Puxeddu, E., Esen, A., et al. (2000) · PubMed · Cited by 262 · see citing works

Crystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPARγ

Uppenberg, J., Svensson, C., Jaki, M., Bertilsson, G., Jendeberg, L., & Berkenstam, A. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31108 · Cited by 261 · see citing works

Androgen Receptor Structural and Functional Elements: Role and Regulation in Prostate Cancer

Dehm, S. M., & Tindall, D. J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0223 · Cited by 252 · see citing works

Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset

Hardy, D. O., Scher, H. I., Bogenreider, T., Sabbatini, P. J., Zhang, Z., Nanus, D. M., & Catterall, J. F. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954049 · Cited by 248 · see citing works

Recognition and Accommodation at the Androgen Receptor Coactivator Binding Interface

Hur, E., Pfaff, S. J., Payne, E. S., Grøn, H., Buehrer, B. M., & Fletterick, R. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020274 · Cited by 235 · see citing works

Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity

Langley, E., Kemppainen, J. A., & Wilson, E. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.92 · Cited by 233 · see citing works

Structural and functional consequences of glutamine tract variation in the androgen receptor

Buchanan, G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh181 · Cited by 225 · see citing works

Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids.

Dahlman‐Wright, K., Wright, A. P. H., Gustafsson, J.-Α., & Carlstedt‐Duke, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49960-7 · Cited by 221 · see citing works

The Linkage of Kennedy's Neuron Disease to ARA24, the First Identified Androgen Receptor Polyglutamine Region-associated Coactivator

Hsiao, P., Lin, D., Nakao, R., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20229 · Cited by 221 · see citing works

Functional in Vivo Interaction between the Amino-Terminal, Transactivation Domain and the Ligand Binding Domain of the Androgen Receptor

Doesburg, P., Kuil, C. W., Berrevoets, C., Steketee, K., Faber, P. W., Mulder, E., Brinkmann, A. O., & Trapman, J. (1997) · Biochemistry · doi:10.1021/bi961775g · Cited by 209 · see citing works

Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone

Askew, E. B., Gampe, R. T., Stanley, T. B., Faggart, J. L., & Wilson, E. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703268200 · Cited by 208 · see citing works

Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.

Lu, S., Tsai, S. Y., & Tsai, M. (1997) · PubMed · Cited by 176 · see citing works

Dependence of Selective Gene Activation on the Androgen Receptor NH2- and COOH-terminal Interaction

He, B., Lee, L. W., Minges, J. T., & Wilson, E. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202809200 · Cited by 168 · see citing works

Molecular Determinants of the Estrogen Receptor-Coactivator Interface

Mak, H. Y., Hoare, S., Henttu, P. M. A., & Parker, M. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3895 · Cited by 166 · see citing works

Protein Secretion and Secretory Processes in Male Accessory Sex Glands

Aumüller, G., & Seitz, J. (1990) · International review of cytology · doi:10.1016/s0074-7696(08)60660-9 · Cited by 154 · see citing works

The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor

Haelens, A., Tanner, T., Denayer, S., Callewaert, L., & Claessens, F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1701 · Cited by 153 · see citing works

Functional analysis of 44 mutant androgen receptors from human prostate cancer.

Shi, X., Ma, A., Xia, L. P., Kung, H.-J., & White, R. D. (2002) · PubMed · Cited by 150 · see citing works

Androgen Receptor: Structural Domains and Functional Dynamics after Ligand‐Receptor Interaction

Roy, A. K., Tyagi, R. K., Song, C. S., Lavrovsky, Y., Ahn, S., Oh, T., & Chatterjee, B. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb04001.x · Cited by 132 · see citing works

Hormone Status Selects for Spontaneous Somatic Androgen Receptor Variants That Demonstrate Specific Ligand and Cofactor Dependent Activities in Autochthonous Prostate Cancer

Han, G., Foster, B. A., Mistry, S. G., Buchanan, G., Harris, J. M., Tilley, W. D., & Greenberg, N. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008207200 · Cited by 123 · see citing works

On the mechanism of DNA binding by nuclear hormone receptors: A structural and functional perspective

Freedman, L. P., & Luisi, B. F. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240510205 · Cited by 122 · see citing works

Mutations at the Boundary of the Hinge and Ligand Binding Domain of the Androgen Receptor Confer Increased Transactivation Function

Buchanan, G., Yang, M., Harris, J. M., Nahm, H. S., Han, G., Moore, N. L. T., Bentel, J. M., Matusik, R. J., Horsfall, D. J., Marshall, V. R., et al. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.1.0581 · Cited by 122 · see citing works

Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor

Dubbink, H. J., Hersmus, R., Verma, C. S., van der Korput, H. A. G. M., Berrevoets, C. A., van Tol, J., Ziel-van der Made, A. C. J., Brinkmann, A. O., Pike, A. C. W., & Trapman, J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0375 · Cited by 118 · see citing works

Androgen receptor corepressors: An overview

Wang, L., Hsu, C., & Chang, C. (2004) · The Prostate · doi:10.1002/pros.20170 · Cited by 115 · see citing works

Induced α-Helix Structure in AF1 of the Androgen Receptor upon Binding Transcription Factor TFIIF

Kumar, R., Betney, R., Li, J., Thompson, E. B., & McEwan, I. J. (2004) · Biochemistry · doi:10.1021/bi035934p · Cited by 107 · see citing works

Transcriptional regulation of prostate kallikrein-like genes by androgen

Wolf, D. A., Schulz, P. J., & Fittler, F. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.5.1376410 · Cited by 98 · see citing works

Skeletal muscle response to tenotomy

Jamali, A. A., Afshar, P., Abrams, R. A., & Lieber, R. L. (2000) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(200006)23:6 · Cited by 97 · see citing works

Mutation of Histidine 874 in the Androgen Receptor Ligand-Binding Domain Leads to Promiscuous Ligand Activation and Altered p160 Coactivator Interactions

Duff, J. M., & McEwan, I. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0231 · Cited by 92 · see citing works

Science behind total androgen blockade: from gene to combination therapy.

Labrie, F., Bèlanger, A., Dupont, A., The, V. L., Simard, J., & Labrie, C. (1993) · PubMed · Cited by 91 · see citing works

Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.

Powell, S. M., Christiaens, V., Voulgaraki, D., Waxman, J., Claessens, F., & Bevan, C. L. (2004) · Endocrine Related Cancer · doi:10.1677/erc.0.0110117 · Cited by 90 · see citing works

Androgen Specificity of a Response Unit Upstream of the Human Secretory Component Gene Is Mediated by Differential Receptor Binding to an Essential Androgen Response Element

Verrijdt, G., Schoenmakers, E., Alen, P., Haelens, A., Peeters, B., Rombauts, W., & Claessens, F. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.9.0347 · Cited by 85 · see citing works

Functional domains of the human androgen receptor

Jenster, G., van der Korput, J. A. G. M., Trapman, J., & Brinkmann, A. O. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90402-5 · Cited by 80 · see citing works

Natural Disordered Sequences in the Amino Terminal Domain of Nuclear Receptors: Lessons from the Androgen and Glucocorticoid Receptors

McEwan, I. J., Lavery, D. N., Fischer, K., & Watt, K. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05001 · Cited by 80 · see citing works

Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression.

Brooke, G. N., Parker, M. G., & Bevan, C. L. (2008) · Oncogene · doi:10.1038/sj.onc.1210955 · Cited by 79 · see citing works

Androgen Receptor Regulation of G1 Cyclin and Cyclin‐Dependent Kinase Function in the CWR22 Human Prostate Cancer Xenograft

Gregory, C. W., Johnson, R. T., Presnell, S. C., Mohler, J. L., & French, F. S. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02213.x · Cited by 68 · see citing works

Endocrine Therapy for Prostate Cancer

Labrie, F. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30247-0 · Cited by 65 · see citing works

Ligand responsiveness in human prostate cancer: structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors.

McDonald, S. M., Brive, L., Agus, D. B., Scher, H. I., & Ely, K. R. (2000) · PubMed · Cited by 64 · see citing works

Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors

Berrevoets, C., Veldscholte, J., & Mulder, E. A. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90313-l · Cited by 63 · see citing works

Nuclear receptors spring into action

Parker, M. G., & White, R. (1996) · Nature Structural Biology · doi:10.1038/nsb0296-113 · Cited by 61 · see citing works

Steroid/nuclear receptor coactivators

Chen, J. D. (2000) · Vitamins and hormones · doi:10.1016/s0083-6729(00)58032-7 · Cited by 59 · see citing works

The Androgen Receptor T877A Mutant Recruits LXXLL and FXXLF Peptides Differently than Wild-Type Androgen Receptor in a Time-Resolved Fluorescence Resonance Energy Transfer Assay

Ozers, M. S., Marks, B. D., Gowda, K., Kupcho, K. R., Ervin, K. M., Rosier, T. D., Qadir, N., Eliason, H. C., Riddle, S. M., & Shekhani, M. S. (2006) · Biochemistry · doi:10.1021/bi061321b · Cited by 59 · see citing works

Dual Function of an Amino-terminal Amphipatic Helix in Androgen Receptor-mediated Transactivation through Specific and Nonspecific Response Elements

Callewaert, L., Verrijdt, G., Christiaens, V., Haelens, A., & Claessens, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210744200 · Cited by 59 · see citing works

The presence of a transcription activation function in the hormone‐binding domain of androgen receptor is revealed by studies in yeast cells

Moilanen, A., Rouleau, N., Ikonen, T., Palvimo, J. J., & Jänne, O. A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00791-6 · Cited by 56 · see citing works

Purification, Functional Characterization, and Crystallization of the Ligand Binding Domain of the Retinoid X Receptor

Bourguet, W., Ruff, M., Bonnier, D., Granger, F., Boeglin, M., Chambon, P., Moras, D., & Gronemeyer, H. (1995) · Protein Expression and Purification · doi:10.1006/prep.1995.1079 · Cited by 38 · see citing works

Androgen Receptor Is Targeted to Distinct Subcellular Compartments in Response to Different Therapeutic Antiandrogens

Whitaker, H. C., Hanrahan, S. J., Totty, N., Gamble, S. C., Waxman, J., Cato, A. C. B., Hurst, H. C., & Bevan, C. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0388 · Cited by 37 · see citing works

The human androgen receptor AF1 transactivation domain: interactions with transcription factor IIF and molten-globule-like structural characteristics

Lavery, D. N., & McEwan, I. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341054 · Cited by 36 · see citing works

The Hinge Region of the Androgen Receptor Plays a Role in Proteasome‐Mediated Transcriptional Activation

Tanner, T., Claessens, F., & Haelens, A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.068 · Cited by 34 · see citing works

Bisphenol A (BPA) and cell signaling pathways

Murata, M., & Kang, J. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.002 · Cited by 366 · see citing works

Drug resistance in metastatic castration-resistant prostate cancer

Šeruga, B., Ocaña, A., & Tannock, I. F. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.136 · Cited by 337 · see citing works

Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer

Knudsen, K. E., & Penning, T. M. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.01.002 · Cited by 291 · see citing works

Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?

Attard, G., Cooper, C. S., & de Bono, J. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.11.006 · Cited by 242 · see citing works

Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel

Shen, Z., Zhou, L., Zhang, C., & Xu, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.006 · Cited by 194 · see citing works

Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects

Ferraldeschi, R., Welti, J. C., Luo, J., Attard, G., & Bono, J. S. D. (2014) · Oncogene · doi:10.1038/onc.2014.115 · Cited by 194 · see citing works

Androgen action and metabolism in prostate cancer

Green, S. M., Mostaghel, E. A., & Nelson, P. S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.046 · Cited by 182 · see citing works

Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer

Lamont, K. R., & Tindall, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0469 · Cited by 150 · see citing works

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

Jacob, A., Raj, R., Allison, D. B., & Myint, Z. W. (2021) · Cancers · doi:10.3390/cancers13215417 · Cited by 140 · see citing works

Steroid hormone receptors in cancer development: A target for cancer therapeutics

Ahmad, N., & Kumar, R. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.09.008 · Cited by 126 · see citing works

Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer

Shiota, M., Yokomizo, A., & Naito, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.07.011 · Cited by 124 · see citing works

Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer

Wahab, N. A. A., Lajis, N. H., Abas, F., Othman, I., & Naidu, R. (2020) · Nutrients · doi:10.3390/nu12030679 · Cited by 123 · see citing works

YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer

Abali, G. K., Alptekin, A., Lewis, M. S., Garraway, I. P., & Cinar, B. (2015) · Nature Communications · doi:10.1038/ncomms9126 · Cited by 119 · see citing works

Androgen regulation of gene expression.

(2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)07005-3 · Cited by 117 · see citing works

The hallmarks of castration-resistant prostate cancers

Katsogiannou, M., Ziouziou, H., Karaki, S., Andrieu, C., de Villeneuve, M. H., & Rocchi, P. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.003 · Cited by 107 · see citing works

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases

Kallio, H. M. L., Hieta, R., Latonen, L., Brofeldt, A., Annala, M., Kivinummi, K. K., Tammela, T. L. J., Nykter, M., Isaacs, W. B., Lilja, H. G., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0172-0 · Cited by 100 · see citing works

Steroidogenic cytochrome P450 17A1 structure and function

Burris‐Hiday, S. D., & Scott, E. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111261 · Cited by 94 · see citing works

Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer

Khurana, N., & Sikka, S. C. (2018) · Cancers · doi:10.3390/cancers10100352 · Cited by 91 · see citing works

Androgen receptor gene mutation, rearrangement, polymorphism.

Eisermann, K., Wang, D., Jing, Y., Pascal, L. E., & Wang, Z. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-4683.2013.09.15 · Cited by 91 · see citing works

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells

Leach, D. A., Mohr, A., Giotis, E. S., Cil, E., Isac, A. M., Yates, L. L., Barclay, W., Zwacka, R. M., Bevan, C. L., & Brooke, G. N. (2021) · Nature Communications · doi:10.1038/s41467-021-24342-y · Cited by 87 · see citing works

Menthol Inhibits the Proliferation and Motility of Prostate Cancer DU145 Cells

Wang, Y., Wang, X., Yang, Z., Zhu, G., Chen, D., & Meng, Z. (2012) · Pathology & Oncology Research · doi:10.1007/s12253-012-9520-1 · Cited by 88 · see citing works

Revising the role of the androgen receptor in breast cancer

Fioretti, F. M., Sita-Lumsden, A. R., Bevan, C. L., & Brooke, G. N. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0030 · Cited by 86 · see citing works

CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis

Penfold, L., Woods, A., Muckett, P. J., Nikitin, A. Y., Kent, T. R., Zhang, S., Graham, R., Pollard, A., & Carling, D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0585 · Cited by 79 · see citing works

Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer

Montgomery, B., Eisenberger, M. A., Rettig, M. B., Chu, F. M., Пили, Р., Stephenson, J. J., Vogelzang, N. J., Koletsky, A. J., Nordquist, L. T., Edenfield, W. J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1432 · Cited by 81 · see citing works

Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer

Khurana, N., & Sikka, S. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092066 · Cited by 78 · see citing works

Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer

Antonarakis, E. S., & Armstrong, A. J. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.23 · Cited by 71 · see citing works

Testosterone, financial risk-taking, and pathological gambling.

Stenstrom, E. P., & Saad, G. (2011) · Journal of Neuroscience Psychology and Economics · doi:10.1037/a0025963 · Cited by 70 · see citing works

Mini-review: Foldosome regulation of androgen receptor action in prostate cancer

Cano, L. Q., Lavery, D. N., & Bevan, C. L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.023 · Cited by 70 · see citing works

Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer

Lucarelli, G. T., Rutigliano, M., Galleggiante, V., Giglio, A., Palazzo, S., Ferro, M., Simone, C., Bettocchi, C., Battaglia, M., & Ditonno, P. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1069711 · Cited by 69 · see citing works

Allosteric Conversation in the Androgen Receptor Ligand-Binding Domain Surfaces

Grosdidier, S., Carbó, L. R., Buzón, V., Brooke, G. N., Nguyen, P., Baxter, J. D., Bevan, C. L., Webb, P., Estébanez‐Perpiñá, E., & Fernández‐Recio, J. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1281 · Cited by 68 · see citing works

Pro-survival and anti-apoptotic properties of androgen receptor signaling by oxidative stress promote treatment resistance in prostate cancer

Shiota, M., Yokomizo, A., & Naito, S. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0232 · Cited by 70 · see citing works

Recent developments in antiandrogens and selective androgen receptor modulators

Haendler, B., & Cleve, A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.002 · Cited by 68 · see citing works

Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer

Chen, Q., Munoz, E., & Ashong, D. (2024) · Cancers · doi:10.3390/cancers16030663 · Cited by 64 · see citing works

Molecular Pathways: Targeting Resistance in the Androgen Receptor for Therapeutic Benefit

Mostaghel, E. A., Plymate, S. R., & Montgomery, B. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3601 · Cited by 61 · see citing works

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer

Lohiya, V., Aragon‐Ching, J. B., & Sonpavde, G. (2016) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s34535 · Cited by 59 · see citing works

Constitutive Activity of the Androgen Receptor

Chan, S. C., & Dehm, S. M. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-417197-8.00011-0 · Cited by 59 · see citing works

The AR dependent cell cycle: Mechanisms and cancer relevance

Schiewer, M. J., Augello, M. A., & Knudsen, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.033 · Cited by 58 · see citing works

Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer

Knudsen, K. E., & Kelly, W. K. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.33 · Cited by 57 · see citing works

Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration‐resistant prostate cancer

Bismar, T. A., Yoshimoto, M., Duan, Q., Liu, S., Sircar, K., & Squire, J. A. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04116.x · Cited by 58 · see citing works

Androgen Receptor Survival Signaling Is Blocked by Anti-β2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer Cells

Huang, W., Zhau, H. E., & Chung, L. W. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092759 · Cited by 55 · see citing works

Molecular alterations and emerging targets in castration resistant prostate cancer

Lorente, D., & Bono, J. S. D. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2013.12.004 · Cited by 55 · see citing works

Abiraterone in the treatment of metastatic castration-resistant prostate cancer

Mostaghel, E. A. (2014) · Cancer Management and Research · doi:10.2147/cmar.s39318 · Cited by 55 · see citing works

A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities

Kounatidou, E. E., Nakjang, S., McCracken, S. R., Dehm, S. M., Robson, C. N., Jones, D. L., & Gaughan, L. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz286 · Cited by 52 · see citing works

The role of DAB2IP in androgen receptor activation during prostate cancer progression

Wu, K., Liu, J., Tseng, S.-F., O’Brien-Gore, C., Ning, Z., Sharifi, N., Fazli, L., Gleave, M. E., Kapur, P., Xiao, G., et al. (2013) · Oncogene · doi:10.1038/onc.2013.143 · Cited by 52 · see citing works

Repression of Androgen Receptor Activity by HEYL, a Third Member of the Hairy/Enhancer-of-split-related Family of Notch Effectors

Lavery, D. N., Villaronga, M. Á., Walker, M. M., Patel, A., Belandia, B., & Bevan, C. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.198655 · Cited by 51 · see citing works

FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer

Jones, D. L., Wade, M., Nakjang, S., Chaytor, L., Grey, J., Robson, C. N., & Gaughan, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4927 · Cited by 49 · see citing works

Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer

Khurana, N., Kim, H., Chandra, P. K., Talwar, S., Sharma, P., Abdel‐Mageed, A. B., Sikka, S. C., & Mondal, D. (2017) · Oncology Reports · doi:10.3892/or.2017.5932 · Cited by 50 · see citing works

Androgen receptor variation affects prostate cancer progression and drug resistance

McCrea, E. M., Sissung, T. M., Price, D. K., Chau, C. H., & Figg, W. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.001 · Cited by 49 · see citing works

Regulation of Androgen-Responsive Transcription by the Chromatin Remodeling Factor CHD8

Menon, T., Yates, J. A., & Bochar, D. A. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0421 · Cited by 49 · see citing works

Adaptation and clonal selection models of castration‐resistant prostate cancer: Current perspective

Ahmed, M., & Li, L. (2012) · International Journal of Urology · doi:10.1111/iju.12005 · Cited by 48 · see citing works

Mechanisms of Resistance to Intermittent Androgen Deprivation in Patients with Prostate Cancer Identified by a Novel Computational Method

Morken, J. D., Packer, A., Everett, R. A., Nagy, J. D., & Kuang, Y. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3162 · Cited by 47 · see citing works

Androgen regulation of epithelial–mesenchymal transition in prostate tumorigenesis

Matuszak, E. A., & Kyprianou, N. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.32 · Cited by 48 · see citing works

Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives

Nadiminty, N., & Gao, A. C. (2011) · World Journal of Urology · doi:10.1007/s00345-011-0771-3 · Cited by 47 · see citing works

H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility

Giambartolomei, C., Seo, J.-H., Schwarz, T., Freund, M. K., Johnson, R., Spisák, S., Baca, S. C., Gusev, A., Mancuso, N., Paşaniuc, B., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.11.007 · Cited by 48 · see citing works

A Comprehensive Overview of Small-Molecule Androgen Receptor Degraders: Recent Progress and Future Perspectives

Ha, S., Luo, G., & Xiang, H. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01487 · Cited by 48 · see citing works

Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study

Kutasovic, J. R., Reed, A. E. M., Males, R., Sim, S., Saunus, J. M., Dalley, A. J., McEvoy, C. R. E., Dedina, L., Miller, G. C., Peyton, S., et al. (2018) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.118 · Cited by 45 · see citing works

Interplay Between Genomic Alterations and Androgen Receptor Signaling During Prostate Cancer Development and Progression

Nyquist, M. D., & Dehm, S. M. (2013) · Hormones and Cancer · doi:10.1007/s12672-013-0131-4 · Cited by 43 · see citing works

Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions

Mohammad, O. S., Nyquist, M. D., Schweizer, M. T., Balk, S. P., Corey, E., Plymate, S. R., Nelson, P. S., & Mostaghel, E. A. (2017) · Cancers · doi:10.3390/cancers9120166 · Cited by 42 · see citing works

Androgen receptor molecular biology and potential targets in prostate cancer

Wilson, E. M. (2010) · Therapeutic Advances in Urology · doi:10.1177/1756287210372380 · Cited by 40 · see citing works

Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells

Liao, C., Chen, L., Luethy, A., Kim, Y., Kani, K., MacLeod, A. R., & Gross, M. E. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0138 · Cited by 40 · see citing works

Pharmacology and Clinical Use of Sex Steroid Hormone Receptor Modulators

Cleve, A., Fritzemeier, K., Haendler, B., Heinrich, N., Möller, C., Schwede, W., & Wintermantel, T. M. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-30726-3_24 · Cited by 37 · see citing works

Mouse Prostate Cancer Cell Lines Established from Primary and Postcastration Recurrent Tumors

Liao, C., Liang, M., Cohen, M. B., Flesken‐Nikitin, A., Jeong, J. H., Nikitin, A. Y., & Roy‐Burman, P. (2010) · Hormones and Cancer · doi:10.1007/s12672-009-0005-y · Cited by 36 · see citing works

Androgen Receptor Signalling in Prostate Cancer: The Functional Consequences of Acetylation

Lavery, D. N., & Bevan, C. L. (2010) · BioMed Research International · doi:10.1155/2011/862125 · Cited by 36 · see citing works

Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer

McBeth, L., Grabnar, M., Selman, S. H., & Hinds, T. D. (2015) · International Journal of Endocrinology · doi:10.1155/2015/384860 · Cited by 35 · see citing works

Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms

Verma, S., Prajapati, K. S., Kushwaha, P. P., Shuaib, M., Singh, A. K., Kumar, S., & Gupta, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.45 · Cited by 36 · see citing works

The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance

Cronin, R., Brooke, G. N., & Prischi, F. (2021) · Oncogene · doi:10.1038/s41388-021-01810-9 · Cited by 32 · see citing works

Structures of androgen receptor bound with ligands: advancing understanding of biological functions and drug discovery

Sakkiah, S., Ng, H. W., Tong, W., & Hong, H. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1192131 · Cited by 35 · see citing works

Classical nuclear hormone receptor activity as a mediator of complex biological responses: A look at health and disease

Yen, P. M. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.07.005 · Cited by 33 · see citing works

Design, Synthesis, and Biological Evaluation of Nonsteroidal Cycloalkane[d]isoxazole-Containing Androgen Receptor Modulators

Poutiainen, P., Oravilahti, T., Peräkylä, M., Palvimo, J. J., Ihalainen, J. A., Laatikainen, R., & Pulkkinen, J. T. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300233k · Cited by 33 · see citing works

Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells

Qu, F., Gu, Y. Q., Wang, Q., He, M., Zhou, F., Sun, J., Wang, G., & Peng, Y. H. (2020) · Investigational New Drugs · doi:10.1007/s10637-020-00901-w · Cited by 33 · see citing works

Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: Past, present and future perspectives

Ha, S., Zhu, J., Xiang, H., & Luo, G. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109192 · Cited by 34 · see citing works

The roles of cytosolic quality control proteins, SGTA and the BAG6 complex, in disease

Benarroch, R., Austin, J. M., Ahmed, F., & Isaacson, R. L. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.11.002 · Cited by 32 · see citing works

GENETIC DETERMINANTS OF PROSTATE CANCER: A REVIEW

Král, M., Rosinska, V., Študent, V., Grepl, M., Hrabec, M., & Bouchal, J. (2011) · Biomedical Papers · doi:10.5507/bp.155.2011.001 · Cited by 31 · see citing works

Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy

O’Neill, D. J., Jones, D. L., Wade, M., Grey, J., Nakjang, S., Guo, W., Cork, D. M. W., Davies, B. R., Wedge, S. R., Robson, C. N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4347 · Cited by 30 · see citing works

ARF Represses Androgen Receptor Transactivation in Prostate Cancer

Lu, W., Xie, Y., Ma, Y., Matusik, R. J., & Chen, Z. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1294 · Cited by 30 · see citing works

Relationship between LSD1 expression and E-cadherin expression in prostate cancer

Wang, M., Liu, X., Jiang, G., Chen, H., Guo, J., & Weng, X. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-0915-2 · Cited by 30 · see citing works

Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells

Khurana, N., Talwar, S., Chandra, P. K., Sharma, P., Abdel‐Mageed, A. B., Mondal, D., & Sikka, S. C. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3641 · Cited by 30 · see citing works

A review of the effects and molecular mechanisms of dimethylcurcumin (ASC‐J9) on androgen receptor‐related diseases

Hu, H., Zhou, H., & Xu, D. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13811 · Cited by 26 · see citing works

Targeting sex steroid biosynthesis for breast and prostate cancer therapy

POUTANEN, M. H., Thulin, M. H., & Härkönen, P. L. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00609-y · Cited by 28 · see citing works

WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer

Leach, D. A., Powell, S. M., & Bevan, C. L. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0319 · Cited by 25 · see citing works

In Silico Identification of Piperazine Linked Thiohydantoin Derivatives as Novel Androgen Antagonist in Prostate Cancer Treatment

Bhati, S., Kaushik, V., & Singh, J. (2018) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-018-9734-5 · Cited by 25 · see citing works

Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells

Khurana, N., Chandra, P. K., Kim, H., Abdel‐Mageed, A. B., Mondal, D., & Sikka, S. C. (2020) · Antioxidants · doi:10.3390/antiox9010068 · Cited by 24 · see citing works

Circular RNA cir‐ITCH Is a Potential Therapeutic Target for the Treatment of Castration‐Resistant Prostate Cancer

Li, S., Yu, C., Zhang, Y., Liu, J., Jia, Y., Sun, F., Zhang, P., Li, J., Guo, L., Xiao, H., et al. (2020) · BioMed Research International · doi:10.1155/2020/7586521 · Cited by 24 · see citing works

The Culinary-Medicinal Mushroom Coprinus comatus as a Natural Antiandrogenic Modulator

Dotan, N., Wasser, S. P., & Mahajna, J. A. (2010) · Integrative Cancer Therapies · doi:10.1177/1534735410383169 · Cited by 24 · see citing works

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens

Dart, D. A., Brooke, G. N., Sita-Lumsden, A. R., Waxman, J., & Bevan, C. L. (2011) · Oncogene · doi:10.1038/onc.2011.591 · Cited by 23 · see citing works

Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: A review

Anantharaman, A., & Friedlander, T. W. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.11.003 · Cited by 23 · see citing works

Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression

Zhang, M., Sun, Y., Huang, C., Luo, J., Zhang, L., Meng, J., Liang, C. Y., & Chang, C. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03966-4 · Cited by 21 · see citing works

In touch with your feminine side: how oestrogen metabolism impacts prostate cancer

Rahman, H. P., Hofland, J., & Foster, P. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0118 · Cited by 21 · see citing works

Structural and molecular insights into the mechanism of resistance to enzalutamide by the clinical mutants in androgen receptor (AR) in castration-resistant prostate cancer (CRPC) patients

Khan, A., Mao, Y., Tahreem, S., Wei, D., & Wang, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.058 · Cited by 20 · see citing works

In Silico Evaluation of the Binding Energies of Androgen Receptor Agonists in Wild-Type and Mutational Models

de Albuquerque, A. C. C., Bezerra, K. S., Vianna, J. F., Batista, S. D. O., Neto, J. X., Campos, D. M. D. O., Oliveira, J. I. N., Galvao, D. S., & Fulco, U. L. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01103 · Cited by 20 · see citing works

Synthesis and Biological Evaluation of Second-Generation Tropanol-Based Androgen Receptor Modulators

Sundén, H., Holland, M. C., Poutiainen, P., Jääskeläinen, T. J., Pulkkinen, J. T., Palvimo, J. J., & Olsson, R. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501995n · Cited by 20 · see citing works

Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine Therapies

Quistini, A., Chierigo, F., Fallara, G., Depalma, M., Tozzi, M., Maggi, M., Jannello, L. M. I., Pellegrino, F., Mantica, G., Terracciano, D., et al. (2025) · Research and Reports in Urology · doi:10.2147/rru.s388265 · Cited by 19 · see citing works

Mining the plasma-proteome associated genes in patients with gastro-esophageal cancers for biomarker discovery

Vizeacoumar, F. S., Guo, H., Dwernychuk, L., Zaidi, A., Freywald, A., Wu, F., Vizeacoumar, F. J., & Ahmed, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-87037-w · Cited by 19 · see citing works

Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration‐dependent modulation of multiple nuclear receptor‐mediated pathways in androgen‐responsive prostate cancer cell LNCaP

Wang, T. T. Y., Schoene, N. W., Kim, E., & Kim, Y. S. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21906 · Cited by 19 · see citing works

AR activates YAP/TAZ differentially in prostate cancer

Salem, O., Jia, S., Qian, B., & Hansen, C. G. (2023) · Life Science Alliance · doi:10.26508/lsa.202201620 · Cited by 18 · see citing works

Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3

Djigoué, G. B., Kenmogne, L. C., Roy, J., Maltais, R., & Poirier, D. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.049 · Cited by 18 · see citing works

Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells*

Brooke, G. N., Gamble, S. C., Hough, M. A., Begum, S., Dart, D. A., Odontiadis, M., Powell, S. M., Fioretti, F. M., Bryan, R. A., Waxman, J., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036764 · Cited by 17 · see citing works

Hexim‐1 modulates androgen receptor and the TGF‐β signaling during the progression of prostate cancer

Mascareno, E. J., Belashov, I. A., Siddiqui, M. A. Q., Liu, F., & Dhar-Mascareño, M. (2011) · The Prostate · doi:10.1002/pros.21510 · Cited by 16 · see citing works

Icilin induces G1 arrest through activating JNK and p38 kinase in a TRPM8-independent manner

Kim, S.-H., Kim, S. Y., Park, E., Kim, J., Park, H. H., So, I., Kim, S. J., & Jeon, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.094 · Cited by 16 · see citing works

Precision medicine applications in prostate cancer

McCrea, E. M., Lee, D. K., Sissung, T. M., & Figg, W. D. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918776920 · Cited by 16 · see citing works

The Role of Androgen Receptor Mutations in Progression of Prostate Cancer

(2013) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608051298113010006 · Cited by 1 · see citing works

Androgen receptor in prostate cancer: cause or cure?

Bevan, C. L. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.09.006 · Cited by 9 · see citing works

The androgen receptor: genetic considerations in the development and treatment of prostate cancer

Cude, K. J., Dixon, S. C., Guo, Y., Lisella, J., & Figg, W. D. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050372 · Cited by 43 · see citing works

Androgen Receptor Function in Prostate Cancer Progression

Klocker, H., Eder, I. E., Comuzzi, B., Bartsch, G. H., & Čulig, Z. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-224-3_6 · Cited by 7 · see citing works

Androgen Receptor in Prostate Cancer

Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780 · see citing works